Regional News
Youdao 2024 Annual General Meeting of Shareholders
BEIJING, Dec. 10, 2024 /PRNewswire/ -- As announced on November 14, 2024, the Company is going to hold its annual general meeting of shareholders ("AGM") at itsBeijing offices on December 12, 2024 at 3:00 p.m. – 5:00 p.m. (Beijing Time). To watch the live broadcasting of the AGM, please click the...
Foreign businesses choosing Shanghai as national hub
BEIJING, Dec. 10, 2024 /PRNewswire/ -- A news report from chinadaily.com.cn:
AQUASTRONG Unveils Comprehensive Pool Circulation System Solutions: From Filtration to Heating
HONG KONG, Dec. 10, 2024 /PRNewswire/ -- AQUASTRONG
KONJAKUSO by Funbound Co., Ltd. Now Offers Luxury and Premium Rental Properties on Homes & Villas by Marriott Bonvoy
YASU and OSAKA, Japan, Dec. 10, 2024 /PRNewswire/ -- Funbound Co., Ltd., a company that specializes in the renovation of vacant houses and buildings into high-end private lodgings under the KONJAKUSO brand, announced that select rental properties are now available on Homes & Villas by Marriott Bo...
Global Times: Tears, triumphs and titles: Oscar reflects on eight years with Chinese club Shanghai Port
BEIJING, Dec. 10, 2024 /PRNewswire/ -- After nearly eight memorable years in China, Brazilian footballer Oscar dos Santos Emboaba Junior, commonly known as Oscar, is contemplating whether to stay as his contract with Chinese Super League (CSL) club Shanghai Port nears its expiration at the end of...
Jinxin Technology Holding Company Announces Closing of US$5 Million Initial Public Offering
SHANGHAI, China, Dec. 9, 2024 /PRNewswire/ -- Jinxin Technology Holding Company (the "Company") (Nasdaq: NAMI), an innovative digital content service provider inChina, today announced the closing of its initial public offering (the "Offering") of 1,250,000 American Depositary Shares ("ADSs") at a...
Nona Biosciences and Kodiak Sciences Partner on Next-Generation Antibody Therapies for Ophthalmic Diseases
CAMBRIDGE, Mass., Dec. 9, 2024 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), ranging from target validation and antibody discovery through preclinical research, today announced a collaboration with Kodiak Sciences Inc. (...
IASO Bio Presented Study Findings on the Impact of CAR T-Cell Persistence on Clinical Outcomes in Relapsed/Refractory Multiple Myeloma with Equecabtagene Autoleucel(FUCASO) Myeloma at 2024 ASH
SHANGHAI and NANJING, China and SAN JOSE, Calif., Dec. 9, 2024 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today shared findings via a poster ...
NTT Group Chooses Evidian Identity Governance & Administration as the Cornerstone of their Identity Management Infrastructure in Japan
One of the largest IGA deployments in Japan, ensuring governance and
scalability for identity and rights management for 250 000 employees within the
NTT Group
PARIS, Dec. 10, 2024 /PRNewswire/ -- Eviden
GoodWe Named Among 2024 Forbes China Go-International Series Top 30 Brands
DENVER, Dec. 9, 2024 /PRNewswire/ -- GoodWe, a global leader in solar inverter manufacturing and energy solutions, has been listed among the Top 30 Brands in the 2024 Forbes China Go-International Series, recognizing its excellence in globalization, innovation, and shaping global markets. Cameal...
Momcozy Unveils Heartwarming Christmas Campaign: "Joy for All, Love for You"
NEW YORK, Dec. 9, 2024 /PRNewswire/ -- Momcozy
2024 ESMO Asia: TransThera announces clinical data of tinengotinib in combination with atezolizumab (PD-L1) in biliary tract carcinoma (BTC)
NANJING, China and GAITHERSBURG, Md., Dec. 9, 2024 /PRNewswire/ -- TransThera Sciences Nanjing, Inc. (the "TransThera") announced the poster presentation at the 2024 European Society For Medical Oncology (ESMO) Asia Congress to discuss the clinical study of tinengotinib in combination with atezol...
WAT Medical Sponsors American Headache Society 2024 Scottsdale Headache Symposium
VANCOUVER, BC, Dec. 9, 2024 /PRNewswire/ -- WAT Medical Enterprise proudly sponsored the 2024 Scottsdale Headache Symposium, organized by the American Headache Society fromNovember 14-17 in Scottsdale, AZ. This annual event brought together a multidisciplinary audience of neurologists, general p...
Deck the Halls with Clean Floors: Enjoy Discounts on YEEDI Robot Vacuums This Holiday Season
SAN FRANCISCO, Dec. 9, 2024 /PRNewswire/ -- Leading robot vacuum brand YEEDI, today announced huge discounts on several of its leading robot vacuum models in a special Holiday Season promotion. As the holiday season gets underway, make sure your home is spotlessly clean for your loved ones this h...
Lunit Marks Go-Live in Groundbreaking National AI Cancer Screening Program in BreastScreen NSW
Lunit INSIGHT MMG integrated into the clinical workflow of Australia's BreastScreen New South Wales to assist in reading approximately 31,000 mammography exams annually SEOUL, South Korea, Dec. 9, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer d...
Taoping Signs Non-binding Letter of Intent to Acquire Yunti; Transformational Acquisition Would Substantially Improve Taoping's Annual Revenue, Expand its Addressable Market, and Leverage its Current Portfolio
SHENZHEN, China, Dec. 9, 2024 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company"), a provider of innovative smart cloud platform services and solutions, new media and artificial intelligence (AI) solutions, today announced that it has signed a non-binding letter of intent to acquire 100% o...
Actinogen randomizes first US participant in XanaMIA phase 2b/3 Alzheimer's disease trial
* Late-stage trial in Alzheimer's opens 10 sites in US, with results due in 2025 and 2026 * Appoints US-based Chief Commercial Officer, Andrew Udell * Xanamem's unique ability to control brain cortisol draws widespread coverage in the Australian media. SYDNEY, Dec. 9, 2024 /PRNewswire/ -- A...
Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate
BEIJING, Dec. 9, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that the National Medical Products Administration of...
U Power and Major Shareholder Chatchaval Jiaravanon Outline Strategic Collaboration for 2025
Third-generation member of Thailand's Charoen Pokphand Group and Fortune magazine owner reinforces commitment to U Power's innovative EV battery solutions SHANGHAI, Dec. 9, 2024 /PRNewswire/ -- U Power Limited (the "Company" or "U Power"), today announced a strategic meeting between CEO Jia Li a...
Noah Showcases Global Expansion and Investment Product Leadership at 2024 Corporate Open Day
* Accelerating global expansion into emerging markets with new brands * Global investment allocation strategies and expanded product offerings drive long-term value for clients * Expanding comprehensive service matrix to address evolving client needs globally SHANGHAI, Dec. 9, 2024 /PRNewswi...
Week's Top Stories
Most Reposted
UTP LAUNCHES MALAYSIA'S FIRST BACHELOR IN INTEGRATED ENGINEERING PROGRAMME
[Picked up by 314 media titles]
2024-12-27 13:17COCONEXT 2024 - FIRST EVER INTERNATIONAL COCONUT CONFERENCE HOLD IN VIETNAM
[Picked up by 296 media titles]
2024-12-31 14:18Dahua Technology Obtains ISO 37301 Compliance Management System Certification
[Picked up by 275 media titles]
2024-12-30 15:33CKGSB Professor Mei Jianping Launches Global Indices Tracking Impressionist, Contemporary, and Chinese Art Markets
[Picked up by 251 media titles]
2024-12-31 22:30ebm-papst A&NZ Achieves Complete Operational Carbon Neutrality in appropriate Scope 1,2 and 3 criterion in 2023
[Picked up by 250 media titles]
2024-12-25 15:45